Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,430,066 papers from all fields of science
Search
Sign In
Create Free Account
Condoms, Unspecified
Known as:
Condom
, Condoms
, Prophylactic
A contraceptive device consisting of a thin rubber or latex sheath worn over the penis during intercourse.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Anti-Infective Agents
Condoms, Male
Contraceptive methods
Female Condoms
Expand
Narrower (2)
CONDOM,LATEX,LUBRICATED
CONDOM,NON-LATEX,SPERMICIDAL
Broader (3)
Contraceptive Devices
Contraceptive Devices, Male
Family Planning
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled…
Leslie Carol Botha
British medical journal
2010
Corpus ID: 9061636
Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade…
Expand
Highly Cited
2010
Highly Cited
2010
Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use.
D. Campoccia
,
L. Montanaro
,
P. Speziale
,
C. R. Arciola
Biomaterials
2010
Corpus ID: 13329853
Highly Cited
2009
Highly Cited
2009
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable…
J. Weber
,
John A Thompson
,
+9 authors
S. O'Day
Clinical Cancer Research
2009
Corpus ID: 5516763
Purpose: Diarrhea (with or without colitis) is an immune-related adverse event (irAE) associated with ipilimumab. A randomized…
Expand
Review
2008
Review
2008
Challenges in the development of an HIV-1 vaccine
D. Barouch
Nature
2008
Corpus ID: 4417964
The development of a safe and effective human immunodeficiency virus (HIV)-1 vaccine is a critically important global health…
Expand
Highly Cited
2004
Highly Cited
2004
Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.
D. Pastrana
,
C. Buck
,
+6 authors
J. Schiller
Virology
2004
Corpus ID: 24035599
Review
2002
Review
2002
Ventriculostomy-related Infections: A Critical Review of the Literature
A. Lozier
,
R. Sciacca
,
Mario Romagnoli
,
E. Connolly
Neurosurgery
2002
Corpus ID: 40146011
OBJECTIVE To provide a critical evaluation of the published literature describing risk factors for ventriculostomy-related…
Expand
Highly Cited
2001
Highly Cited
2001
Occult Carcinoma in Prophylactic Oophorectomy Specimens: Prevalence and Association With BRCA Germline Mutation Status
Terence Colgan
,
Joan Murphy
,
D. Cole
,
S. Narod
,
B. Rosen
American Journal of Surgical Pathology
2001
Corpus ID: 29496482
Prophylactic oophorectomy (PO) is an option for women at increased risk for ovarian carcinoma. In this study the value of…
Expand
Highly Cited
2000
Highly Cited
2000
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.
Åsa Gustafsson
,
V. Levitsky
,
+7 authors
M. Masucci
Blood
2000
Corpus ID: 2443022
A semiquantitative polymerase chain reaction assay was used to monitor the blood levels of Epstein-Barr virus (EBV)-DNA in 9…
Expand
Highly Cited
1997
Highly Cited
1997
The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
P. Rebulla
,
G. Finazzi
,
+6 authors
G. Sirchia
New England Journal of Medicine
1997
Corpus ID: 24855809
BACKGROUND Prophylactic platelet transfusions are usually administered to patients receiving myelotoxic chemotherapy when their…
Expand
Highly Cited
1997
Highly Cited
1997
Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.
Deborah Schrag
,
Karen M. Kuntz
,
J. Garber
,
Jane C. Weeks
New England Journal of Medicine
1997
Corpus ID: 6886940
BACKGROUND Women with BRCA1 or BRCA2 mutations have an increased risk of breast cancer and ovarian cancer. Prophylactic…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE